Product Details for ANDA 077312
FENTANYL CITRATE (FENTANYL CITRATE)
EQ 0.2MG BASE
Marketing Status: Discontinued
EQ 0.4MG BASE
Marketing Status: Discontinued
EQ 0.6MG BASE
Marketing Status: Discontinued
EQ 0.8MG BASE
Marketing Status: Discontinued
EQ 1.2MG BASE
Marketing Status: Discontinued
EQ 1.6MG BASE
Marketing Status: Discontinued
EQ 0.2MG BASE
Marketing Status: Discontinued
Active Ingredient: FENTANYL CITRATE
Proprietary Name: FENTANYL CITRATE
Dosage Form; Route of Administration: TROCHE/LOZENGE; TRANSMUCOSAL
Strength: EQ 0.2MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A077312
Product Number: 001
Approval Date: Oct 30, 2009
Applicant Holder Full Name: PAR PHARMACEUTICAL INC
Marketing Status: Discontinued
Patent and Exclusivity Information
FENTANYL CITRATE (FENTANYL CITRATE)
Proprietary Name: FENTANYL CITRATE
Dosage Form; Route of Administration: TROCHE/LOZENGE; TRANSMUCOSAL
Strength: EQ 0.2MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A077312
Product Number: 001
Approval Date: Oct 30, 2009
Applicant Holder Full Name: PAR PHARMACEUTICAL INC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 0.4MG BASE
Marketing Status: Discontinued
Active Ingredient: FENTANYL CITRATE
Proprietary Name: FENTANYL CITRATE
Dosage Form; Route of Administration: TROCHE/LOZENGE; TRANSMUCOSAL
Strength: EQ 0.4MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A077312
Product Number: 002
Approval Date: Oct 30, 2009
Applicant Holder Full Name: PAR PHARMACEUTICAL INC
Marketing Status: Discontinued
Patent and Exclusivity Information
FENTANYL CITRATE (FENTANYL CITRATE)
Proprietary Name: FENTANYL CITRATE
Dosage Form; Route of Administration: TROCHE/LOZENGE; TRANSMUCOSAL
Strength: EQ 0.4MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A077312
Product Number: 002
Approval Date: Oct 30, 2009
Applicant Holder Full Name: PAR PHARMACEUTICAL INC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 0.6MG BASE
Marketing Status: Discontinued
Active Ingredient: FENTANYL CITRATE
Proprietary Name: FENTANYL CITRATE
Dosage Form; Route of Administration: TROCHE/LOZENGE; TRANSMUCOSAL
Strength: EQ 0.6MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A077312
Product Number: 003
Approval Date: Oct 30, 2009
Applicant Holder Full Name: PAR PHARMACEUTICAL INC
Marketing Status: Discontinued
Patent and Exclusivity Information
FENTANYL CITRATE (FENTANYL CITRATE)
Proprietary Name: FENTANYL CITRATE
Dosage Form; Route of Administration: TROCHE/LOZENGE; TRANSMUCOSAL
Strength: EQ 0.6MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A077312
Product Number: 003
Approval Date: Oct 30, 2009
Applicant Holder Full Name: PAR PHARMACEUTICAL INC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 0.8MG BASE
Marketing Status: Discontinued
Active Ingredient: FENTANYL CITRATE
Proprietary Name: FENTANYL CITRATE
Dosage Form; Route of Administration: TROCHE/LOZENGE; TRANSMUCOSAL
Strength: EQ 0.8MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A077312
Product Number: 004
Approval Date: Oct 30, 2009
Applicant Holder Full Name: PAR PHARMACEUTICAL INC
Marketing Status: Discontinued
Patent and Exclusivity Information
FENTANYL CITRATE (FENTANYL CITRATE)
Proprietary Name: FENTANYL CITRATE
Dosage Form; Route of Administration: TROCHE/LOZENGE; TRANSMUCOSAL
Strength: EQ 0.8MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A077312
Product Number: 004
Approval Date: Oct 30, 2009
Applicant Holder Full Name: PAR PHARMACEUTICAL INC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 1.2MG BASE
Marketing Status: Discontinued
Active Ingredient: FENTANYL CITRATE
Proprietary Name: FENTANYL CITRATE
Dosage Form; Route of Administration: TROCHE/LOZENGE; TRANSMUCOSAL
Strength: EQ 1.2MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A077312
Product Number: 005
Approval Date: Oct 30, 2009
Applicant Holder Full Name: PAR PHARMACEUTICAL INC
Marketing Status: Discontinued
Patent and Exclusivity Information
FENTANYL CITRATE (FENTANYL CITRATE)
Proprietary Name: FENTANYL CITRATE
Dosage Form; Route of Administration: TROCHE/LOZENGE; TRANSMUCOSAL
Strength: EQ 1.2MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A077312
Product Number: 005
Approval Date: Oct 30, 2009
Applicant Holder Full Name: PAR PHARMACEUTICAL INC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 1.6MG BASE
Marketing Status: Discontinued
Active Ingredient: FENTANYL CITRATE
Proprietary Name: FENTANYL CITRATE
Dosage Form; Route of Administration: TROCHE/LOZENGE; TRANSMUCOSAL
Strength: EQ 1.6MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A077312
Product Number: 006
Approval Date: Oct 30, 2009
Applicant Holder Full Name: PAR PHARMACEUTICAL INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: FENTANYL CITRATE
Dosage Form; Route of Administration: TROCHE/LOZENGE; TRANSMUCOSAL
Strength: EQ 1.6MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A077312
Product Number: 006
Approval Date: Oct 30, 2009
Applicant Holder Full Name: PAR PHARMACEUTICAL INC
Marketing Status: Discontinued
Patent and Exclusivity Information